Senior Communications Advisor at the NZ Drug Foundation
Given MDMA’s popularity, potential therapeutic uses, and low harm profile, is it time we re-examine how we regulate it here? Drug Foundation Senior Communications Advisor Feilidh Dwyer investigates.
In Aotearoa, scientists, iwi, as well as hobbyists and amateurs are busy researching what psilocybin’s potential could be. So, what’s next for psilocybin in Aotearoa?
Drug Foundation Communications Advisor Feilidh Dwyer visits a thought-provoking MDMA pop-up shop in Utrecht.